Basic Policy for Human Rights
In light of rising global concern for human rights and the societal responsibility of companies to respect human rights, Sumitomo Pharma has respecting human rights as one of the material issues making up the foundation to continue business. In the "Declaration of Conduct: Item 5. Respect Human Rights," we clearly support the Universal Declaration of Human Rights and Core Labour Standards and, in conformance with the UN Guiding Principles on Business and Human Rights, articulates our commitment to complying with laws pertaining to labor and employment in our countries and regions of business. As for measures that concern respecting human rights, in the "Compliance Standard: Item 25. Respect for Human Rights, Prohibition of Discrimination and Harassing Behavior, and Prohibition of Harassment", we clearly reject any discrimination or harassment based on race, nationality, ethnic or social origin, ancestry, ethnicity, age, religion, faith or belief, sex and gender, sexual orientation, gender identity, marital status, academic background, disability, disease, employment status, or any other status.
To prevent and mitigate the human rights risks throughout Sumitomo Pharma Group's business activities, a resolution was passed by the Board of Directors that led to the SMP Group Human Rights Policy. The policy was established and put into force on March 1, 2022, and serves as high-level guidelines for all documents and rules pertaining to efforts aimed at respecting human rights throughout the Group.
In accordance with the policy, the Group provides appropriate work environments, creates systems to carry out human rights due diligence*, identifies adverse impacts on human rights, and works to prevent and mitigate human rights violations while disclosing information appropriately. For all those involved with the Group, including our suppliers and other business partners, we will continue to ask for their understanding and support of this policy, encourage a respect for human rights, show a respect for human rights throughout all value chain, and do business in a way that contributes to greater social sustainability.
* A series of processes for assessing adverse impacts on human rights, responding to survey results, conducting follow-up surveys, and disseminating information about response methods.
Respecting Human Rights Promotion System
Sumitomo Pharma has set up a secretariat under the supervision of an executive officer in charge of promotion of respecting human rights, and the Rules for Promotion of Respecting Human Rights, which stipulates systems and procedures for appropriately promoting respect for human rights in each department, was enacted and enforced on September 1, 2022. Efforts for respecting human rights are shared with the compliance promotion system and the risk management promotion system, and reported to the Board of Directors on a regular basis (at least once a year) for supervision.
Going forward, we will continue to work together with our group companies to promote for respecting human rights.